TY - JOUR
T1 - The mechanisms for tachykinin-induced contractions of the rabbit corpus cavernosum
AU - Takahashi, Ryosuke
AU - Nishimura, Junji
AU - Hirano, Katsuya
AU - Naito, Seiji
AU - Kanaide, Hideo
PY - 2002/11
Y1 - 2002/11
N2 - 1. This study was designed to investigate the mechanisms for the contractions induced by tachykinins (substance P (SP), neurokinin A (NKA) and neurokinin B (NKB)) in the rabbit corpus cavernosum strips, using fura-PE3 fluorimetry and α-toxin permeabilization. 2. Tachykinins induced contractions in the rabbit corpus cavernosum in a concentration-dependent manner. The potency order was SP > NKA > NKB. 3. The tachykinin-induced contractions were enhanced by phosphoramidon (PPAD), an endopeptidase inhibitor, but not by Nω-nitro-L-arginine methylester (L-NAME). 4. The NK 1 receptor selective antagonist, SR 140333 significantly inhibited the tachykinin-induced contractions. Although the NK 2 receptor selective antagonist, SR 48968 alone did not influence the effects of tachykinins, it potentiated the inhibitory effect of SR 140333. The NK 3 receptor selective antagonist, SR142801 had no effect. 5. In the rabbit corpus cavernosum, tachykinins induced sustained increases in [Ca 2+] i and tension in normal PSS, while only small transient increases in [Ca 2+] i and tension were observed in Ca 2+-free solution. 6. In α-toxin permeabilized preparations, tachykinins induced an additional force development at a constant [Ca 2+] i. 7. These results indicated that in the rabbit corpus cavernosum: (1) Tachykinins induced contractions by increasing both the [Ca 2+] i and myofilament Ca 2+ sensitivity; (2) The tachykinin-induced [Ca 2+] i elevations were mainly due to the Ca 2+ influx; (3) Tachykinin-induced contractions were mainly mediated through the activation of NK 1 receptor expressed in the rabbit corpus cavernosum smooth muscle, and affected by the endopeptidase activity and (4) Tachykinins may thus play a role in controlling the corpus cavernosum tone.
AB - 1. This study was designed to investigate the mechanisms for the contractions induced by tachykinins (substance P (SP), neurokinin A (NKA) and neurokinin B (NKB)) in the rabbit corpus cavernosum strips, using fura-PE3 fluorimetry and α-toxin permeabilization. 2. Tachykinins induced contractions in the rabbit corpus cavernosum in a concentration-dependent manner. The potency order was SP > NKA > NKB. 3. The tachykinin-induced contractions were enhanced by phosphoramidon (PPAD), an endopeptidase inhibitor, but not by Nω-nitro-L-arginine methylester (L-NAME). 4. The NK 1 receptor selective antagonist, SR 140333 significantly inhibited the tachykinin-induced contractions. Although the NK 2 receptor selective antagonist, SR 48968 alone did not influence the effects of tachykinins, it potentiated the inhibitory effect of SR 140333. The NK 3 receptor selective antagonist, SR142801 had no effect. 5. In the rabbit corpus cavernosum, tachykinins induced sustained increases in [Ca 2+] i and tension in normal PSS, while only small transient increases in [Ca 2+] i and tension were observed in Ca 2+-free solution. 6. In α-toxin permeabilized preparations, tachykinins induced an additional force development at a constant [Ca 2+] i. 7. These results indicated that in the rabbit corpus cavernosum: (1) Tachykinins induced contractions by increasing both the [Ca 2+] i and myofilament Ca 2+ sensitivity; (2) The tachykinin-induced [Ca 2+] i elevations were mainly due to the Ca 2+ influx; (3) Tachykinin-induced contractions were mainly mediated through the activation of NK 1 receptor expressed in the rabbit corpus cavernosum smooth muscle, and affected by the endopeptidase activity and (4) Tachykinins may thus play a role in controlling the corpus cavernosum tone.
UR - http://www.scopus.com/inward/record.url?scp=0036856402&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036856402&partnerID=8YFLogxK
U2 - 10.1038/sj.bjp.0704938
DO - 10.1038/sj.bjp.0704938
M3 - Article
C2 - 12411416
AN - SCOPUS:0036856402
SN - 0007-1188
VL - 137
SP - 845
EP - 854
JO - British Journal of Pharmacology
JF - British Journal of Pharmacology
IS - 6
ER -